Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 3-(2-(4-(2-methylphenyl)-1-piperazinyl)ethyl)-5,6,7,8,-tetrahydro-1,2,4-triazolo(4,3-a)pyridine Hydrochloride
2. Dapiprazole
3. Remydrial
4. Rev-eyes
1. 72822-13-0
2. Dapiprazole Hcl
3. Rev-eyes
4. Dapiprazole (hydrochloride)
5. Dapiprazolehydrochloride
6. Glamidolo
7. Dapiprazole Monohydrochloride
8. Reversil
9. Af 2139
10. Dapiprazole Hydrochloride [usan]
11. Ds9ujn1i0x
12. Af-2139
13. Remydrial
14. 72822-13-0 (hcl)
15. Dsstox_cid_28595
16. Dsstox_rid_82866
17. Dsstox_gsid_48669
18. 3-(2-(4-(o-tolyl)piperazin-1-yl)ethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine Hydrochloride
19. 5,6,7,8-tetrahydro-3-(2-(4-o-tolyl-1-piperazinyl)ethyl)-s-triazolo(4,3-a)pyridine Monohydrochloride
20. Dapiprazole Hydrochloride (usan)
21. 1,2,4-triazolo(4,3-a)pyridine, 5,6,7,8-tetrahydro-3-(2-(4-(2-methylphenyl)-1-piperazinyl)ethyl)-, Monohydrochloride
22. 5,6,7,8-tetrahydro-3-[2-[4-(2-methylphenyl)-1-piperazinyl]ethyl]-1,2,4-triazolo[4,3-a]pyridine
23. Cas-72822-13-0
24. Unii-ds9ujn1i0x
25. Rev-eyes (tn)
26. Reversil Hydrochloride
27. Glamidolo Hydrochloride
28. Schembl667604
29. Chembl1201044
30. Dtxsid7048669
31. Hy-a0142a
32. Hms3746g11
33. Bcp34410
34. Tox21_113035
35. S5281
36. Akos015966533
37. Tox21_113035_1
38. Ac-8851
39. Ccg-268185
40. Cs-5720
41. Dapiprazole Hydrochloride [mart.]
42. Dapiprazole Hydrochloride [vandf]
43. Ncgc00262927-01
44. 3-[2-[4-(2-methylphenyl)piperazin-1-yl]ethyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine Hydrochloride
45. 3-[2-[4-(2-methylphenyl)piperazin-1-yl]ethyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine,hydrochloride
46. 3-[2-[4-(2-methylphenyl)piperazin-1-yl]ethyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine;hydrochloride
47. As-16932
48. Dapiprazole Hydrochloride [who-dd]
49. Dapiprazole Monohydrochloride [mi]
50. Dapiprazole Hydrochloride, >=98% (hplc)
51. Ft-0665471
52. D03648
53. D82527
54. Dapiprazole Hydrochloride [orange Book]
55. 822d130
56. A837632
57. Q27276579
58. 3-(2-(4-o-tolylpiperazin-1-yl)ethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine Hydrochloride
59. 3-[2-[4-(2-methylphenyl)-1-piperazinyl]ethyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine Hydrochloride
60. 5,6,7,8-tetrahydro-3-(2-(4-(2-methylphenyl)-1-piperazinyl)ethyl)-1,2,4-triazolo(4,3-a)pyridine Monohydrochloride
Molecular Weight | 361.9 g/mol |
---|---|
Molecular Formula | C19H28ClN5 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 4 |
Exact Mass | 361.2033236 g/mol |
Monoisotopic Mass | 361.2033236 g/mol |
Topological Polar Surface Area | 37.2 Ų |
Heavy Atom Count | 25 |
Formal Charge | 0 |
Complexity | 395 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Adrenergic alpha-Antagonists
Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)
Antipsychotic Agents
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)
ABOUT THIS PAGE
97
PharmaCompass offers a list of Dapiprazole Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dapiprazole Hydrochloride manufacturer or Dapiprazole Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dapiprazole Hydrochloride manufacturer or Dapiprazole Hydrochloride supplier.
PharmaCompass also assists you with knowing the Dapiprazole Hydrochloride API Price utilized in the formulation of products. Dapiprazole Hydrochloride API Price is not always fixed or binding as the Dapiprazole Hydrochloride Price is obtained through a variety of data sources. The Dapiprazole Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Dapiprazole HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dapiprazole HCl, including repackagers and relabelers. The FDA regulates Dapiprazole HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dapiprazole HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dapiprazole HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dapiprazole HCl supplier is an individual or a company that provides Dapiprazole HCl active pharmaceutical ingredient (API) or Dapiprazole HCl finished formulations upon request. The Dapiprazole HCl suppliers may include Dapiprazole HCl API manufacturers, exporters, distributors and traders.
click here to find a list of Dapiprazole HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Dapiprazole HCl DMF (Drug Master File) is a document detailing the whole manufacturing process of Dapiprazole HCl active pharmaceutical ingredient (API) in detail. Different forms of Dapiprazole HCl DMFs exist exist since differing nations have different regulations, such as Dapiprazole HCl USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Dapiprazole HCl DMF submitted to regulatory agencies in the US is known as a USDMF. Dapiprazole HCl USDMF includes data on Dapiprazole HCl's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Dapiprazole HCl USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Dapiprazole HCl suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Dapiprazole HCl as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Dapiprazole HCl API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Dapiprazole HCl as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Dapiprazole HCl and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Dapiprazole HCl NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Dapiprazole HCl suppliers with NDC on PharmaCompass.
Dapiprazole HCl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dapiprazole HCl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dapiprazole HCl GMP manufacturer or Dapiprazole HCl GMP API supplier for your needs.
A Dapiprazole HCl CoA (Certificate of Analysis) is a formal document that attests to Dapiprazole HCl's compliance with Dapiprazole HCl specifications and serves as a tool for batch-level quality control.
Dapiprazole HCl CoA mostly includes findings from lab analyses of a specific batch. For each Dapiprazole HCl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dapiprazole HCl may be tested according to a variety of international standards, such as European Pharmacopoeia (Dapiprazole HCl EP), Dapiprazole HCl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dapiprazole HCl USP).